Nov 29, 2025, 16:35
Deferral of Immunosuppression in Acquired Hemophilia
Andreas Tiede, Professor in the Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation at Hannover Medical School, posted on LinkedIn:
”If you’re interested in Acquired Hemophilia A, read the thoughtful comments by Jerome Teitel and Jean St.-Louis about the more careful use of immunosuppressants in these fragile patients.”
Title: Deferral of immunosuppression in acquired hemophilia
Authors: Jerome Teitel, Jean St-Louis
Stay updated with Hemostasis Today.
Acquired Hemophilia
Acquired Hemophilia A
American Society of Hematology
Andreas Tiede
ASH
bleeding disorders
Blood Journal
haemophilia
Health
Hematology
Hemophilia
Hemophilia A
Hemostasis
Hemostasis Today
Hôpital Maisonneuve-Rosemont
Immunosuppression
Jean St-Louis
Jerome Teitel
Medicine
St. Michael’s Hospital
thrombosis
Université de Montréal
University of Toronto
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings